Hormonal Contraception
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Energy Deficiency on Hormones in Contraceptive Users
Effect of Different Sex Hormone Profiles for the Response to Physical Training
Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age
Contraceptive Hormones, Immunity, and Microbiome Evaluation
Stress Reactivity and Hormonal Contraception
Oxytocin and Reward Processing in Women
Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya